---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-103181"
form_type: "8-K/A"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2023-09-22T23:59:59+00:00"
generated_at: "2026-06-10T09:35:19.904157+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pacific Biosciences to issue ~8.9M shares and $101M cash for Omniome milestone

## Summary
- On Sep 20, 2023, PacBio achieved a commercial milestone under the Omniome merger agreement.
- Former Omniome holders will receive approx. $101M cash + 8.9M shares (valued at ~$100M based on 20-day VWAP).
- Shares issuance expected on or about October 4, 2023.

## SEC filing metadata
- accession: 0001104659-23-103181
- form_type: 8-K/A
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2023-09-22T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000110465923103181/0001104659-23-103181-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000110465923103181/tm2326680d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-103181
- JSON: https://secwatch.observer/filing/0001104659-23-103181.json
- Plain text: https://secwatch.observer/filing/0001104659-23-103181.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.